Biohaven Pharmaceutical Holding Company Ltd.
CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH
Last updated:
Abstract:
Disclosed are methods of treating breakthrough migraine in patients using breakthrough CGRP antagonists. Also disclosed are methods for the prophylactic treatment of migraine.
Status:
Application
Type:
Utility
Filling date:
19 Jan 2020
Issue date:
4 Nov 2021